pneumococcal polysaccharide vaccine
GPTKB entity
Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
intramuscular injection
subcutaneous injection |
| gptkbp:approvedBy |
1983
adults over 65 people with certain chronic illnesses |
| gptkbp:ATCCode |
gptkb:J07AL01
|
| gptkbp:boosterRecommended |
certain high-risk groups
|
| gptkbp:brand |
gptkb:Pneumovax_23
gptkb:Pneumo_23 |
| gptkbp:broadcastOn |
single dose
|
| gptkbp:contains |
purified capsular polysaccharides
|
| gptkbp:contraindication |
severe allergic reaction to previous dose
|
| https://www.w3.org/2000/01/rdf-schema#label |
pneumococcal polysaccharide vaccine
|
| gptkbp:notRecommendedFor |
children under 2 years
|
| gptkbp:numberOfSerotypesCovered |
23
|
| gptkbp:prevention |
gptkb:pneumonia
meningitis pneumococcal disease bacteremia |
| gptkbp:sideEffect |
fever
muscle aches pain at injection site |
| gptkbp:target |
gptkb:Streptococcus_pneumoniae
|
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:Streptococcus_pneumoniae
gptkb:Pneumovax_23 |
| gptkbp:bfsLayer |
6
|